Wan Peng - Net Worth and Insider Trading
Wan Peng Net Worth
The estimated net worth of Wan Peng is at least $346,300 dollars as of 2025-04-16. Wan Peng is the Supervisors of Sichuan Kelun Pharmaceutical Co Ltd and owns about 10,000 shares of Sichuan Kelun Pharmaceutical Co Ltd (SZSE:002422) stock worth over $346,300. Details can be seen in Wan Peng's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wan Peng has not made any transactions after 2020-12-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Wan Peng
Wan Peng Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wan Peng owns 1 companies in total, including Sichuan Kelun Pharmaceutical Co Ltd (SZSE:002422) .
Click here to see the complete history of Wan Peng’s form 4 insider trades.
Insider Ownership Summary of Wan Peng
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SZSE:002422 | Sichuan Kelun Pharmaceutical Co Ltd | 2020-12-22 | Supervisors |
Wan Peng Latest Holdings Summary
Wan Peng currently owns a total of 1 stock. Wan Peng owns 10,000 shares of Sichuan Kelun Pharmaceutical Co Ltd (SZSE:002422) as of December 22, 2020, with a value of $346,300.
Latest Holdings of Wan Peng
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SZSE:002422 | Sichuan Kelun Pharmaceutical Co Ltd | 2020-12-22 | 10,000 | 34.63 | 346,300 |
Holding Weightings of Wan Peng
Wan Peng Form 4 Trading Tracker
According to the SEC Form 4 filings, Wan Peng has made a total of 1 transactions in Sichuan Kelun Pharmaceutical Co Ltd (SZSE:002422) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sichuan Kelun Pharmaceutical Co Ltd is the acquisition of 10,000 shares on December 22, 2020, which cost Wan Peng around $193,900.
Insider Trading History of Wan Peng
- 1
Wan Peng Trading Performance
GuruFocus tracks the stock performance after each of Wan Peng's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wan Peng is 13.92%. GuruFocus also compares Wan Peng's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wan Peng within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wan Peng's insider trading performs compared to the benchmark.
Wan Peng Ownership Network
Ownership Network List of Wan Peng
Ownership Network Relation of Wan Peng

Wan Peng Owned Company Details
What does Sichuan Kelun Pharmaceutical Co Ltd do?
Who are the key executives at Sichuan Kelun Pharmaceutical Co Ltd?
Wan Peng is the Supervisors of Sichuan Kelun Pharmaceutical Co Ltd. Other key executives at Sichuan Kelun Pharmaceutical Co Ltd include Executives Lai De Gui , Directors & executives Feng Hao , and Directors & executives Liu Si Chuan .
Sichuan Kelun Pharmaceutical Co Ltd (SZSE:002422) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sichuan Kelun Pharmaceutical Co Ltd (SZSE:002422) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sichuan Kelun Pharmaceutical Co Ltd (SZSE:002422) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sichuan Kelun Pharmaceutical Co Ltd (SZSE:002422)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sichuan Kelun Pharmaceutical Co Ltd Insider Transactions
Wan Peng Mailing Address
Above is the net worth, insider trading, and ownership report for Wan Peng. Currently GuruFocus does not have mailing address information for Wan Peng.